COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007 por M. V. Shestakova

Obter o texto integral

On the centenary of the insulin discovery por I. I. Dedov, M. V. Shestakova

Obter o texto integral

Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study por M. V. Shestakova, E. V. Biryukova

Obter o texto integral

A COMPREHENSIVE ANALYSIS DIABETES OF RISK FACTORS IN PATIENTS WITH CHRONIC PANCREATITIS por M. A. Kunitsyna, M. V. Shestakova

Obter o texto integral

Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases por Е. V. Shlyakhto, M. V. Shestakova

Obter o texto integral

He is a One-Man Army if he is Dedov por M. V. Shestakova, N. B. Lebedev

Obter o texto integral

Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials por M. Sh. Shamkhalova, M. V. Shestakova

Obter o texto integral

COVID-19 and kidneys por M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova

Obter o texto integral

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federati... por O. K. Vikulova, G. R. Galstyan, M. V. Shestakova

Obter o texto integral

Endothelial dysfunction in patients with obesity and type 2 diabetes mellitus or normoglycemia: assessment of specific markers por E. V. Pokrovskaya, E. A. Shestakova, M. V. Shestakova

Obter o texto integral

The role of advanced glycation end products in patogenesis of diabetic nephropathy por A. O. Gavrilova, A. S. Severina, M. S. Shamhalova, M. V. Shestakova

Obter o texto integral

Time in range is a tool for assessing the quality of glycemic control in diabetes por L. A. Suplotova, A. S. Sudnitsyna, N. V. Romanova, M. V. Shestakova

Obter o texto integral

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus por O. K. Vikulova, Zamira Zuraeva, L. V. Nikankina, M. V. Shestakova

Obter o texto integral

Vaccination of patients with diabetes mellitus por M. V. Shestakova, T. V. Nikonova, V. O. Barysheva, N. G. Mokrysheva

Obter o texto integral

Tserebrovaskulyarnye zabolevaniya i sakharnyy diabet 2 tipa por L. A. Chugunova, P. R. Kamchatnov, A. V. Chugunov, M. V. Shestakova

Obter o texto integral

Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy por A. F. Vasilenko, M. V. Shestakova, I. V. Kochetkov, M. I. Karpova

Obter o texto integral

Formation of a system of target indicators for rating and integral evaluation of the efficiency of the organization of the provision of medical care to patients with diabetes melli... por I. A. Mikhailov, V. V. Omelyanovsky, M. V. Shestakova, N. G. Mokrysheva

Obter o texto integral

Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity por E. V. Pokrovskaya, I. A. Sklyanik, E. A. Shestakova, M. V. Shestakova

Obter o texto integral

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on insulin: a network meta-analysis por M. V. Shestakova, G. R. Galstyan, B. B. Kvasnikov, E. E. Erina

Obter o texto integral

On the 100^th anniversary of the Nobel Prize «For the Discovery of Insulin» por S. T. Magerramova, A. S. Odarchenko, Y. A. El-Taravi, D. K. Erikenova, M. V. Shestakova

Obter o texto integral